Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy - Peterson, D E; Barker, N P; Akhmadullina, L I (J Clin Oncol, 2009)